12 Feb 2020 --- Despite a hazy regulatory landscape, the cannabidiol (CBD) space continues to gather pace in terms of NPD and R&D. Now US President Donald Trump has requested US$5 million, from the FY2021 budget, to regulate the CBD industry to allow the Food and Drug Administration (FDA) to continue enforcing protection laws safeguarding patients and consumers. The money would also provide potential regulatory pathways for products containing cannabis and cannabis-derived compounds.
